Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01554020

Blood Sugar Take Care and Glucose Metabolism

Effect of Blood Sugar Take Care on Glucose Metabolism, Determinants of Metabolic Syndrome, and Quality of Life in Prediabetic Adults: A Randomized, Double-blind, Placebo-controlled Study

Status
Withdrawn
Phase
Phase 2
Study type
Interventional
Enrollment
0 (actual)
Sponsor
NewChapter, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This prospective international clinical trial is a two-arm, double-blind, randomized, placebo-controlled, parallel-group, multicenter study. 112 prediabetic subjects will be randomized to Blood Sugar Take Care or placebo. Randomization will be stratified by gender. The intervention period is 12 weeks. The primary outcome is fasting glucose levels.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTBlood Sugar Take CareOne 1200 mg soft gel capsule administered 3X/day for duration of study
DIETARY_SUPPLEMENTPlaceboOne 1200 mg soft-gel capsule administered 3X/day for duration of study

Timeline

Start date
2012-06-01
Primary completion
2013-10-01
Completion
2013-11-01
First posted
2012-03-14
Last updated
2013-03-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01554020. Inclusion in this directory is not an endorsement.

Blood Sugar Take Care and Glucose Metabolism (NCT01554020) · Clinical Trials Directory